Author: Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. Connect on Linkedin

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

Barriers to mealtime insulin include complexity, fear of injections, and lifestyle interference. This multicenter, randomized controlled trial evaluated efficacy, safety, and self-reported outcomes in adults with type 2 diabetes, inadequately controlled on basal insulin, initiating and managing mealtime insulin with a wearable patch versus an insulin pen.

Source: Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

MAP: Just a Suspect or Proven Perp in Crohn’s?

Mycobacterium avium subspecies paratuberculosis (MAP) is under investigation as a cause of the growing global prevalence of Crohn’s disease (CD). Found in meat, milk, water, fruits and vegetables, pastures, and aerosols, this pathogen, which can exist only in mammalian cells, causes a granulomatous enteritis similar to an intestinal tuberculosis known as Johne’s disease in cattle and other ruminants.

Source: MAP: Just a Suspect or Proven Perp in Crohn’s?